RNCOS Releases Report on Generic Drug Market in Canada

Delhi, India (PressExposure) April 19, 2008 -- Canada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. Generics in 2007 accounted for more then 46% prescriptions and 19% sales out of the total pharmaceutical market. The market is currently being driven by several factors, such as patent expiry of several blockbuster drugs, lower costs, cost containment measures by the government, and rapidly aging population, according to "Generic Drug Market in Canada" - a market research report that provides an exhaustive analysis on the generic market in Canada.

The report thoroughly evaluates the factors that distinguish Canada from all other generic markets both in positive and negative ways. A major factor that differentiates the Canadian generic market from the US and most European markets is the comparatively high price of generics and lower price erosion. This allows manufacturers to fetch better margins from their drugs, and is a major reason which is attracting foreign players to enter this market.

Currently, drugs against chronic diseases occupy most of the pharmaceutical market, with cardiovascular drugs holding the top spot. However, strong growth is expected in other chronic segments also, particularly in cancer and diabetes.

Although the market has huge potential, growth can be significantly hampered by recent government regulations and various other challenges. However, the low cost of generics, coupled with billion dollar drug patent expiries, is expected to enable the generic market to continue its double-digit growth in the next five years.

Key Issues & Facts Analyzed

- Evaluation of past, current and future market trends. - Discussion about the size and growth of the market. - Study of various distribution channels prevailing in the market. - Analysis of healthcare indicators. - Future prospects of the generic market. - Profile discussion of key players in this market. - Analysis of various challenges and opportunities for the market.

Key Players Analyzed

This section provides the overview, key facts, and financial information of prominent players in the Canadian generic market, including Teva Pharmaceutical Industries Limited, Apotex Inc, Ratiopharm GmBH, Pharmascience Inc., etc.

Research Methodology Used

Information Sources Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.

Analysis Methods The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.

About RNCOS E-Services Pvt. Ltd.

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.


For more information visit: [http://www.rncos.com/Report/IM598.htm]
Current Industry News: [http://www.rncos.com/Blog/]

Press Release Source: http://PressExposure.com/PR/RNCOS_E~Services_Pvt._Ltd..html

Press Release Submitted On: April 04, 2008 at 5:35 am
This article has been viewed 32594 time(s).